Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 415 of the 415 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. PARTICIPANTS: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and a medical writer, all appointed by The Endocrine Society. EVIDENCE: The Task Force developed this evidenced-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews of published data and considered several other existing meta-analyses and trials. CONSENSUS PROCESS: Multiple e-mail communications, conference calls, and one face-to-face meeting determined consensus. Committees of The Endocrine Society, representatives from endorsing societies, and members of The Endocrine Society reviewed and commented on the drafts of the guidelines. The Australasian Menopause Society, the British Menopause Society, European Menopause and Andropause Society, the European Society of Endocrinology, and the International Menopause Society (co-sponsors of the guideline) reviewed and commented on the draft. CONCLUSIONS: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the climacteric. Benefits may exceed risks for the majority of symptomatic postmenopausal women who are under age 60 or under 10 years since the onset of menopause. Health care professionals should individualize therapy based on clinical factors and patient preference. They should screen women before initiating MHT for cardiovascular and breast cancer risk and recommend the most appropriate therapy depending on risk/benefit considerations. Current evidence does not justify the use of MHT to prevent coronary heart disease, breast cancer, or dementia. Other options are available for those with vasomotor symptoms who prefer not to use MHT or who have contraindications because these patients should not use MHT. Low-dose vaginal estrogen and ospemifene provide effective therapy for the genitourinary syndrome of menopause, and vaginal moisturizers and lubricants are available for those not choosing hormonal therapy. All postmenopausal women should embrace appropriate lifestyle measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have not associated HRT in women 40-49 years with increased risk of breast cancer (161), and there is no evidence that estrogen replacement in women with premature ovarian failure relates to a higher risk of breast cancer ( 162).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [162]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 3×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
Background2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development and implementation of evidence-based guidelines (1).”
Method2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534 · cited 2×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
BackgroundClinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 2×
“Recent guidelines address bonespecific therapies (43).”
BackgroundWriting Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Cited by
Items 601–700 of 883
Associations of plasma sex‐related hormone and protein levels and alcohol dependence
Ho, A. M., Geske, J. R., Pazdernik, V., Waller, T. C., Batzler, A. J., Winham, S. J., & Karpyak, V. M. (2025) · Addiction · doi:10.1111/add.70104
“We inferred menopause status using the national average menopause age of 51 [18].”
The Impact of Hormone Therapy on the Clinical Symptoms of Menopause
Hernández-Angeles, C., & Castelo‐Branco, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-59318-0_13 · Cited by 1
Amenorrhea and Estrogen Disorders in Women with Kidney Disease
Vellanki, K., & Kramer, H. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_10 · Cited by 1
Current Treatment Modalities for the Genitourinary Syndrome of Menopause
Erel, C. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_11 · Cited by 1
Laser Treatment for Vulvovaginal Atrophy
Gambacciani, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_12 · Cited by 1
S3-Leitlinie: Hormonersatztherapie und Krebsrisiko
Ortmann, O., Emons, G., & Tempfer, C. M. (2020) · Gynäkologische Endokrinologie · doi:10.1007/s10304-020-00309-y · Cited by 1
The Role of Aesthetics in Wellness
Mikhail, A. A., & Ngor, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.032 · Cited by 3
Reproductive System: Pregnancy and Postpartum Wellness
Ogunyemi, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.011 · Cited by 1
Volle, D. C., & DeBonis, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.023 · Cited by 1
Allergic, Infectious, and Immunological Processes
Riaz, O., Orimaye, S. O., Al-Khateeb, T., Sodeke, P. O., Awujoola, A. O., & Goodkin, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.012 · Cited by 2
Sheehan’s Syndrome Presenting as Postpartum Psychosis
Chiu, H. H. C., Masamayor, E. M. I., Pilit-Hizon, M. B. B., Uy, A. B., Anonuevo-Cruz, M. C., & Jasul, G. (2021) · Acta Medica Philippina · doi:10.47895/amp.vi0.3505 · Cited by 1
Syed, R., & Rambabu, K. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.1101015 · Cited by 3
“Progestin (Wiegratz and Kuhl, 2004) medications, like drospirenone, are used in birth control pills to prevent pregnancies and are included in hormone replacement therapy (Langer et al., 2021; Stuenkel et al., 2015) for menopausal women, among other applications (Kuhl, 2005).”
BackgroundThe Interrelationship of Menopause and Type 2 Diabetes Mellitus
Lathia, T. B., & Kalra, S. (2020) · Diabetes Research - Open Journal · doi:10.17140/droj-6-146 · Cited by 1
Melchert, T. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.004 · Cited by 1
S3-Leitlinie: Hormonersatztherapie und Krebsrisiko
Ortmann, O., Emons, G., & Tempfer, C. M. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-04504-2 · Cited by 1
▼Prasterone for vulvar and vaginal atrophy
(2019) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2019.000034 · Cited by 1
Strowitzki, T. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_44 · Cited by 1
Thurman, A. R., Hull, M. L., Stuckey, B. G. A., Hatheway, J., Zack, N., Mauck, C. K., & Friend, D. R. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002210 · Cited by 2
Mohammed, K. S., & Murad, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4377 · Cited by 1
Self-citationBaber, R. (2017) · Climacteric · doi:10.1080/13697137.2017.1395565 · Cited by 1
“Sadly, 1 year on, the evidence suggests that we are still in a situation where the menopause is considered either to be (1) not mainstream, (2) not important, or (3) too difficult.”
BackgroundHypopituitarism, Causes, Diagnosis, Management and Mortality
Fountas, A., & Karavitaki, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64277-0 · Cited by 1
Postmenopausal hormone therapy and risk of venous thromboembolism: what about progesterone?
Scarabin, P. (2019) · BMJ · doi:10.1136/bmj.l601 · Cited by 1
Hormone Replacement Therapy: Risks and Benefits
Lima, L. G., Tayfour, N. M., Lemos, P. C. O., Alves, M. F., Ferreira, I. M., & Gomes, E. V. (2020) · Integrative Journal of Medical Sciences · doi:10.15342/ijms.7.242 · Cited by 1
“The systemic use of hormones has some adverse effects, such as the possibility of developing breast cancer, thus should not be indicated randomly [3,4].”
BackgroundIsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.052 · Cited by 2
Gompel, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64947-4 · Cited by 1
Self-citationSabra, H. K., Fayoud, A. M., Elsebaie, M. A. T., Hamad, M., Siddiq, A., Kereet, I. M., Elshnoudy, I. A., Shalma, N. M., & Elewidi, M. M. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3324690/v1 · Cited by 1
Prevention of Cardiovascular Disease in Women
(2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681081120115010007
The response to ospemifene in normal human breast tissue cultures
Pickar, J. H. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000668
Guidelines, guidelines, guidelines!
Currie, H. D., Morris, E., & Simpson, P. (2016) · Post Reproductive Health · doi:10.1177/2053369116666210
Sex Hormones and Related Compounds, Including Hormonal Contraceptives
Hrometz, S. L. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.07.005
Behandlung menopausaler Beschwerden: Praktische Aspekte aus der aktuellen NICE-Leitlinie
Mueck, A. O. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0094-y
Žarković, M. (2016) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1663023z
Pharmacotherapies for Menopause Management: Hormonal Options
Pinkerton, J. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_4
Self-citationMartini, J., Knappe, S., Garthus‐Niegel, S., & Hoyer, J. (2017) · Frauenheilkunde up2date · doi:10.1055/s-0042-122585
“[99] Stuenkel CA, Davis SR, Gompel A et al.”
BackgroundShurpyak, S. О., Пирогова, В. И., & Малачинська, М. Й. (2017) · Reproductive Endocrinology · doi:10.18370/2309-4117.2017.37.65-68
Richardson, M. K. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001295
Medicinal products and dietary supplements affecting unfavorable symptoms of climacterium
Vosátka, J., Vaňková, B., Dvořáčková, S., & Malý, J. (2018) · Praktické lékárenství · doi:10.36290/lek.2018.031
“Podmínkou je také přístup pacientky k léčbě a ochota léčiva užívat (18).”
GSM management: need for interprofessional collaborative practice
Bachmann, G. A., & Phillips, N. A. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001328
Improving the Care of Women with Vulvovaginal Atrophy in Primary Care
Wiers, S. G. (2019) · Advances in Family Practice Nursing · doi:10.1016/j.yfpn.2018.12.002
Menopause and Hormone Replacement Therapy
Coleman, M. L. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.mhrt_overview
Kontrazeption über 40 – was ist zweckmäßig und wie lange ist sie sinnvoll
Binder, H. (2019) · Journal für Gynäkologische Endokrinologie/Österreich · doi:10.1007/s41974-019-0091-y
Hormone Replacement Therapy in Premature Ovarian Insufficiency
Bruni, V., & Pampaloni, F. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_10 · Cited by 1
Erişkinde Hipopitüitarizmin Tanı ve Tedavisi
Şişman, P., & Gül, Ö. Ö. (2019) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.510272
Schilddrüsenerkrankungen in der Peri- und Postmenopause
Mondorf, A. W., Meyer, G., & Bojunga, J. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-4490-y
Renaissance der Hormontherapie
Mann, C., Rogenhofer, N. N., Mahner, S., & Thaler, C. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-9705-3
Anagnostis, P. G., & Stevenson, J. C. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.12.004
Androgen synthesis in menopause and diagnosis of causes of hyperandrogenism in menopause
Бурка, О. А., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.50.31-37
Balan, V. E., Владиславовна, Т. Е., Titchenko, Y. P., & Сергеевна, Б. Т. (2020) · Medical alphabet · doi:10.33667/2078-5631-2019-4-33(408)-38-43
Estrogen Replacement in Turner Syndrome
Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A., Backeljauw, P. F., Gravholt, C. H., Sas, T., & Mauras, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-34150-3_5
Self-citation„Genitourinary syndrome of menopause“ – vaginale Östrogene im Vergleich
Stute, P. (2020) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-020-00135-2
Management of menopausal women with a history of endometriosis
Ermakova, E. I., & Yureneva, S. V. (2020) · GYNECOLOGY · doi:10.26442/20795696.2019.6.190662
MacGregor, E. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108869102.008
Koval, M. V., & Обоскалова, Т. А. (2020) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2020.161
Mindfulness, Meditation, and Yoga
Budd, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.028
Work, Love, Play, and Joie de Vivre
Groningen, N. V., IsHak, W. W., Ganjian, S., Ong, M. K., & Slusser, W. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.045
Acupuncture, Herbs, and Ayurvedic Medicine
Postolov, L., & Gilberg-Lenz, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.031
Circadian Rhythm in the Digital Age
Ezzat-Velinov, M., & Guarneri, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.035
Chaudhry, M., Gordon, A., Tadros, E., Sun, C., Tobia, G., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.019
The Personalized Wellness Life Plan
IsHak, W. W., Bart, R., Gohar, Y., Lorea, N., Eskander, L., Chang, T., Cohen, S., Furman, K., Nayyar, P. P., & DeBonis, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.050
Exercise, Dance, Tai Chi, Pilates, and Alexander Technique
Altug, Z. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.025
Louy, C., Sweet, C., Pollock, G. A., de Zagon, C., Louy, Z., Weiss, J. M., & Maher, D. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.017
Pharmaceuticals and Alternatives for Wellness
Parisi, T., Heath, B., Wen, R. Y., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.024
The Arts in Health Settings: Inspirational, Educational, and Therapeutic Approaches to Wellness
Bucciarelli, A., Ellison, G. K., Sommer, E. K., & Spooner, H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.036
Screening and Assessment Methods for Wellness
Greenberg, J. M., Castillo, E. G., IsHak, W. W., & Wells, K. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.002
The Role of Leisure, Recreation, and Play in Health and Well-Being
Payne, L. L., & An, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.048 · Cited by 2
Positive Neuropsychology, Cognitive Rehabilitation, and Neuroenhancement
Pimental, P. A., O'Hara, J. B., Christopher, J., & Ciampanelli, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.030
Wellness in Children and Adolescents
Zanko, C., & Stuber, M. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.016
Connection, Compassion, and Community
Hedrick, R., & Jones, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.043
Wellness Interventions for Chronicity and Disability
Klimowicz, A., Schussel, L., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.044
Mays, A. M., Whiteman, E., & Rosen, S. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.015
Developing Purpose, Meaning, and Achievements
Vilhauer, J. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.041
Sleep, Rest, and Relaxation in Improving Wellness
Ngor, A., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.026
The Biopsychosocial Assessment
Somjee, L., & Esbitt, S. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.003 · Cited by 1
Wellness and the Genito-Urinary System
EILBER, K. S., & Lee, U. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.010
Marin, K., Tobia, G., Bakhoum, A., Naghdechi, L., Korouri, S., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.027 · Cited by 1
Cardiovascular and Pulmonary Wellness
IsHak, W. W., & Herrera, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.008
Wellness in Endocrine and Metabolic Disorders
Clevenger, S., Eskander, L., Lin, T. Y., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.013
The Concept of Wellness in Psychiatric and Substance-Use Disorders
Awad, A. G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.006
Wellness and Whole-Person Care
Hutchinson, T. A., & Hutchinson, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.049
Herrera, N., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.040
Wellness in Cancer and Neoplastic Diseases
Bashmi, L., & IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.018
Wellness Interventions for Physicians and Healthcare Professionals
Goldenberg, M., & Danovitch, I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.021
Neurological and Neurosurgical Disorders and Wellness
Ding, K., & Yang, I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.007
Gastrointestinal System and Wellness
Robbins, L., & Feldman, E. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.009
Goodwin, A. M., Koczo, A., Jones, S. A., McNeil, M., & Dolan, B. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_21
Barrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
Schilddrüsenerkrankungen in der Peri- und Postmenopause
Mondorf, A. W., Meyer, G., & Bojunga, J. (2021) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-021-00186-z
Cardiovascular risk assessment: just do it
Stuenkel, C. A. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001794
Self-citationHormonas bioidénticas y fitoestrógenos
Pérez-Galván, A. C., López-Tarabay, C., Castillo-Mora, J. A., Arce-Sánchez, L., Alonso-Salvador, L., Malanco-Hernández, L. M., Martínez-Cruz, N., López-Juárez, N., & Valle-Carmona, Y. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000067
Praxisnahe menopausale Hormontherapie
Svejda, B. (2021) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-021-00153-x
Suprainguinal and infrainguinal peripheral artery disease—Do women present differently than men
Ho, V. T., Ho, M., & Chandra, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822959-0.00024-9
Carşote, M., Petrova, E. N., Radu, O., Goldstein, A. L., Ghemigian, A. M., & Valea, A. (2016) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2016.3.10 · Cited by 1
Hypogonadotropic Hypogonadism in a Female Patient with Thalassemia Major
Gomes, R. R. (2021) · International Journal of Blood Research and Disorders · doi:10.23937/2469-5696/1410066
Life After the Women’s Health Initiative: Where Do We Stand?
Mospan, C. M. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.474
Einfluss auf Depression und Demenz
Keck, C., & Segerer, S. E. (2021) · gynäkologie + geburtshilfe · doi:10.1007/s15013-021-4206-y
Animal Studies for Effect of Exercise to Postmenopausal Women
Agustiningsih, D. (2017) · Journal of Yoga and Physiotherapy · doi:10.19080/jyp.2017.02.555585
“Management for postmenopausal women based on the evidence presented in the several documents: EMAS position statements and clinical guides, published in Maturitas between 2010 and 2016 [1], a guideline from the UK National Institute for Health and Care Excellence (NICE) [2], a clinical practice guideline from the Endo…”
MethodDirective clinique no 422e : Ménopause et maladies cardiovasculaires
Abramson, B. L., Black, D., Christakis, M. K., Fortier, M. P., & Wolfman, W. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.10.004
El budismo y el problema del absoluto
Ferrer, A. (2004) · Dialnet (Universidad de la Rioja)
Alterungsprävention in der Gendermedizin: Frauenmedizin
Bitzer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_8
Metadata
- Authors
- Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-11
- Volume
- 100
- Issue
- 11
- Pages
- 3975-4011
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2162957019
- Cited by
- 884
- References
- 414
- Citations by year
- 2026: 79 · 2025: 96 · 2024: 66 · 2023: 69 · 2022: 82 · 2021: 96 · 2020: 121 · 2019: 89 · 2018: 75 · 2017: 57 · 2016: 47 · 2015: 4
- FWCI
- 52.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- menopause, hormone replacement therapy, vasomotor symptoms, climacteric, postmenopausal women, cardiovascular risk screening, breast cancer risk, ospemifene, vaginal estrogen, genitourinary syndrome of menopause, vaginal moisturizers, lifestyle intervention, personalized treatment
- MeSH terms
- Contraindications, Age Factors, Breast Neoplasms, Cardiovascular Diseases, Female, Humans, Menopause, Terminology as Topic, Risk Factors, Severity of Illness Index, Estrogen Replacement Therapy, Evidence-Based Medicine, Hot Flashes, Female Urogenital Diseases, Venous Thromboembolism, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.